FDA Inspection 1241011 — Jagsonpal Pharmaceuticals Ltd.
The FDA completed an inspection of Jagsonpal Pharmaceuticals Ltd. on April 3, 2024 in Alwar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 3, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Alwar (India)